Table 3.
Incident of End Point Events of Study Population
| Variables | N=53 065 | Years of Exposure to cumhs‐CRP | P Value | |||
|---|---|---|---|---|---|---|
| Nonexposed (N=29 496) | 1‐Exposed (N=14 433) | 2‐Exposed (N=6147) | 3‐Exposed (N=2989) | |||
| CVD [n (%)] | 1057 (2.0) | 455 (1.5) | 299 (2.1) | 189 (3.1) | 114 (3.5) | <0.001 |
| MI [n (%)] | 273 (0.5) | 97 (0.3) | 88 (0.6) | 50 (0.8) | 38 (1.3) | <0.001 |
| Stroke [n (%)] | 795 (1.5) | 362 (1.2) | 216 (1.5) | 140 (2.3) | 77 (2.6) | <0.001 |
| Hemorrhagic stroke [n (%)] | 136 (0.3) | 57 (0.2) | 39 (0.3) | 29 (0.5) | 11 (0.4) | 0.001 |
| Ischemic stroke [n (%)] | 672 (1.3) | 309 (1.0) | 184 (1.3) | 113 (1.8) | 66 (2.2) | <0.001 |
cumhs‐CRP indicates cumulative high‐sensitivity C‐reactive protein; CVD, cardiovascular disease; MI, myocardial infarction.